Intermittent Claudication Market

Intermittent claudication is a type of muscle pain especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply.
Intermittent Claudication Market aims to provide a comprehensive presentation of the global market for Intermittent Claudication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intermittent Claudication. Intermittent Claudication Market contains market size and forecasts of Intermittent Claudication in global, including the following market information:
Global Intermittent Claudication Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Intermittent Claudication market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
by Treatment Process Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intermittent Claudication include I'ROM GROUP(DNAVEC Corporation), Nuo Therapeutics Inc., Kowa Company Ltd., LTT Bio-Pharma, Pluristem Therapeutics Inc., Nuo Therapeutics, Inc.(Aldagen, Inc.), Genovate Biotechnology Co., Ltd., Novartis AG and ID Pharma Co., Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intermittent Claudication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intermittent Claudication Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Intermittent Claudication Market Segment Percentages, by Type, 2022 (%)
by Treatment Process
Medication Therapies
Revascularization
by Drug Type
ALD-301
DVC1-0101
K-134
LT-0101
PLX-PAD
Tirasemtiv
Global Intermittent Claudication Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Intermittent Claudication Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Home Healthcare
Others
Global Intermittent Claudication Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Intermittent Claudication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intermittent Claudication revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intermittent Claudication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
I'ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc.
Kowa Company Ltd.
LTT Bio-Pharma
Pluristem Therapeutics Inc.
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis AG
ID Pharma Co., Ltd
Helixmith Co., Ltd.
G. Pohl-Boskamp GmbH & Co. KG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intermittent Claudication, market overview.
Chapter 2: Global Intermittent Claudication market size in revenue.
Chapter 3: Detailed analysis of Intermittent Claudication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intermittent Claudication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.